Extrahepatic cancers
1 paper1 finding
- Humans1
Associations
1Metabolic dysfunction-associated steatotic liver disease
upin humans1HR 1.5
1 study
Metabolic dysfunction-associated steatotic liver disease
upin humans1HR 1.5
Metabolic dysfunction-associated steatotic liver disease raises the risk of extrahepatic cancers in humans (HR 1.50, 95% CI 1.01-2.25).
Humansin individuals with chronic HBV infectionmedian follow-up: 13.7 years
Concurrent MASLD and Long-term Outcomes in HBV-infected Individuals: A Population-based Cohort Study
Biomedical and environmental sciences : BES20 Jul 2026
More on Metabolic dysfunction-associated steatotic liver disease
Latest
2 in 12 monthsCancer Medicine
Cancer Risk Among Young Adults With Clinically Diagnosed Fatty Liver Disease: A Nationwide Cohort Study in South Korea
Cohort study in peopleCancer
Biomedical and Environmental Sciences
Concurrent MASLD and Long-term Outcomes in HBV-infected Individuals: A Population-based Cohort Study
Cohort study of 120,913 peoplePopulations